Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women
- PMID: 28451851
- DOI: 10.1007/s11906-017-0738-x
Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women
Abstract
Purpose of review: The present obesity epidemic particularly affects African-American women. Whether the obesity epidemic will alter the hypertension phenotype in African-American women is entertained.
Recent findings: The prevalence of morbid obesity is steadily increasing in African-American women, who are prone to developing hypertension (HTN) even in the absence of obesity. The obesity-associated hypertension phenotype is characterized by marked sympathetic nervous system activation and resistance/refractoriness to antihypertensive therapy. Weight loss achieved through lifestyle interventions and pharmacotherapy has a modest and rarely sustained antihypertensive effect. In contrast, bariatric surgery has a sustained antihypertensive effect, as evidenced by normalization of hypertension or lessening of antihypertensive therapy. The prevalence of HTN and its obesity-associated phenotype is likely to increase in African-American women over the next decades. Obese African-American women may be increasingly referred for bariatric surgery when hypertension remains uncontrolled despite lifestyle interventions and pharmacological therapy for weight loss and blood pressure (BP) control.
Keywords: African-American women; Bariatric surgery; Hypertension; Hypertension phenotype; Obesity; Weight loss.
Similar articles
-
Characteristics and resolution of hypertension in obese African American bariatric cohort.Sci Rep. 2021 Jan 18;11(1):1683. doi: 10.1038/s41598-021-81360-y. Sci Rep. 2021. PMID: 33462353 Free PMC article.
-
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.J Hypertens. 2012 Jun;30(6):1047-55. doi: 10.1097/HJH.0b013e3283537347. J Hypertens. 2012. PMID: 22573071
-
Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.Curr Hypertens Rep. 2017 Feb;19(2):18. doi: 10.1007/s11906-017-0713-6. Curr Hypertens Rep. 2017. PMID: 28243928 Review.
-
Secondary hypertension: obesity and the metabolic syndrome.J Clin Hypertens (Greenwich). 2008 Jul;10(7):567-74. doi: 10.1111/j.1751-7176.2008.08178.x. J Clin Hypertens (Greenwich). 2008. PMID: 18607142 Free PMC article. Review.
-
Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.J Clin Hypertens (Greenwich). 2013 Jan;15(1):14-33. doi: 10.1111/jch.12049. Epub 2012 Dec 18. J Clin Hypertens (Greenwich). 2013. PMID: 23282121 Free PMC article. Review.
Cited by
-
Hypertension in Premenopausal and Postmenopausal Women.Curr Hypertens Rep. 2019 Aug 26;21(10):74. doi: 10.1007/s11906-019-0979-y. Curr Hypertens Rep. 2019. PMID: 31451980 Review.
-
CD36 Modulates Fasting and Preabsorptive Hormone and Bile Acid Levels.J Clin Endocrinol Metab. 2018 May 1;103(5):1856-1866. doi: 10.1210/jc.2017-01982. J Clin Endocrinol Metab. 2018. PMID: 29546316 Free PMC article.
-
Mitochondrial inefficiency in infants born to overweight African-American mothers.Int J Obes (Lond). 2018 Jul;42(7):1306-1316. doi: 10.1038/s41366-018-0051-z. Epub 2018 Mar 3. Int J Obes (Lond). 2018. PMID: 29568109 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials